Harrow Health, Inc. (HROW) vs Kardigan, Inc. (KARD)

A side-by-side comparison of Harrow Health, Inc. and Kardigan, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HROW vs KARD

growth of $100 · dividends reinvested · last 1y
HROW -18.8% (-18.8%/yr)KARD -30.7% (-30.7%/yr)HROW compounded faster over this window
80100120Start $100$81$69
HROW KARD

HROW vs KARD: by the numbers

  • •KARD is the larger company ($1.25B vs $1.14B market cap).
  • •Both run net losses; KARD's is the smaller (0.00% vs -13.51% net margin).

Metrics side by side

Valuation

MetricHROWKARD
P/S ratio4.12N/A
P/B ratio74.752.03
FCF yield0.47%N/A

Profitability

MetricHROWKARD
Gross margin73.28%0.00%
Operating margin14.18%0.00%
Net margin-13.51%0.00%
ROE-244.91%N/A
ROIC1.81%-57.11%

Growth (annualized)

MetricHROWKARD
Revenue CAGR (5Y)34.52%N/A
Total return CAGR (5Y)27.66%N/A

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.